Amanote Research
Register
Sign In
A2aR AS ONE OF NOVEL IMMUNE CHECKPOINTS, AND TUMOR-INFILTRATING LYMPHOCYTES IN DIFFUSE LARGE B-Cell LYMPHOMA
Hematological Oncology
- United Kingdom
doi 10.1002/hon.19_2631
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Cancer Research
Oncology
Hematology
Date
June 1, 2019
Authors
X. Wang
T. Zhang
B. Meng
Q. Zhai
X. Ren
L. Li
P. Wang
H. Zhang
Publisher
Wiley
Related search
Prognostic Implication of Programmed Death-1-Positive Tumor-Infiltrating Lymphocytes in Diffuse Large B-Cell Lymphoma
The Korean Journal of Pathology
Immune Escape Mechanisms in Diffuse Large B-Cell Lymphoma
ISRN Immunology
Diffuse Large B-Cell Lymphoma: Using Immune Biomarkers to Define Novel Therapies
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Immune Cell Constitution in the Tumor Microenvironment Predicts the Outcome in Diffuse Large B-Cell Lymphoma
Haematologica
Hematology
Diffuse Large B-Cell Lymphoma
Identification of Ezrin-Radixin-Moesin Proteins as Novel Regulators of Pathogenic B-Cell Receptor Signaling and Tumor Growth in Diffuse Large B-Cell Lymphoma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma
Seminars in Hematology
Hematology
KLHL6 Is a Tumor Suppressor Gene in Diffuse Large B-Cell Lymphoma
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Diffuse Large B-Cell Lymphoma Presenting as a Cardiac Mass
Texas Heart Institute Journal
Medicine
Cardiovascular Medicine
Cardiology